Test-retest reproducibility of a rapid method to measure brain oxygen metabolism
Cerebral metabolic rate of oxygen (CMRO2) is an important index of tissue viability and brain function, but this parameter cannot yet be measured routinely on clinical scanners. Recently, a noninvasive technique was proposed which estimates global CMRO2 by concomitantly measuring oxygen‐extraction‐f...
Saved in:
Published in | Magnetic resonance in medicine Vol. 69; no. 3; pp. 675 - 681 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.03.2013
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cerebral metabolic rate of oxygen (CMRO2) is an important index of tissue viability and brain function, but this parameter cannot yet be measured routinely on clinical scanners. Recently, a noninvasive technique was proposed which estimates global CMRO2 by concomitantly measuring oxygen‐extraction‐fraction using T2‐relaxation‐under‐spin‐tagging MRI and pulse oximetry, and cerebral‐blood‐flow using phase‐contrast MRI. This study sought to establish a standard acquisition procedure for this technique and to evaluate its test–retest reproducibility in healthy subjects. Each subject was examined in five sessions and each session included two measurements. Intrasession, intersession, and intersubject coefficients of variation for CMRO2 were found to be 3.84 ± 1.44% (N = 7, mean ± standard deviation), 6.59 ± 1.56%, and 8.80% respectively. These reproducibility values were comparable or slightly superior to 15O positron emission tomography (PET) results reported in the literature. It was also found that oxygen‐extraction‐fraction and cerebral‐blood‐flow tended to co‐vary across sessions (P = 0.002) and subjects (P = 0.01), and their coefficients of variation were greater than that of CMRO2. The simplicity and reliability features may afford this global CMRO2 technique great potential for immediate clinical applications. Magn Reson Med, 2013. © 2012 Wiley Periodicals, Inc. |
---|---|
Bibliography: | istex:6854CE3C6BBCD1455511A930FA74E74F28F6594F ark:/67375/WNG-7VS7H365-G NIH - No. R01 MH084021; No. R01 NS067015; No. R21 AG034318; No. R01 AG033106 ArticleID:MRM24295 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0740-3194 1522-2594 1522-2594 |
DOI: | 10.1002/mrm.24295 |